Screening for ovarian cancer risk
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This trial tests whether a nudge or reminder can help doctors refer patients with suspicious ovarian masses to a gynecologic oncologist. If you have a finding on an imaging test that suggests possible ovarian cancer, this study may help connect you with the right specialist.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had an imaging test (like an ultrasound or CT) that showed a suspicious mass in your ovary.
- You do not already have a diagnosis of ovarian cancer.
- The imaging was not ordered by a gynecologic oncologist.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a transvaginal ultrasound can be used as a screening tool for ovarian cancer in women at higher risk. It may help find ovarian cancer earlier in people who have a strong family or personal cancer history.
This trial is looking at how doctors can better use the CA125 blood test to find ovarian cancer earlier. If you are being tested for ovarian cancer in primary care, this study might help improve how future patients are diagnosed.
This study looks at how well a blood test called CA-125, along with other markers and checkups, can detect ovarian cancer early. It’s for women considered low risk who will do regular blood tests and possibly a vaginal ultrasound if results suggest it.
This study collects tissue samples and medical information from people at higher risk for ovarian cancer or undergoing gynecologic surgery. Researchers use this data to develop better ways to detect and prevent ovarian cancer early.
This study looks at older adults with newly diagnosed epithelial ovarian cancer and checks health factors that can affect treatment, like day-to-day function and support needs. It may help doctors choose better care plans for older patients by understanding risks and needs early.
This study is testing a new blood test that may help detect ovarian cancer earlier. Researchers want to see if it can tell the difference between people with ovarian cancer and those without it.
Hear when a new Ovarian cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.